date:Oct 29, 2012
directional use regulations.
Confidence is also accused of failing to meet current good manufacturing practice (cGMP) regulations for dietary supplements.
This firm made unfounded claims to consumers. Products with unapproved disease claims are dangerous because they may cause consumers to delay or avoid legitimate treatments, said Melinda K Plaisier, FDAs acting associate commissioner for regulatory affairs.
The FDA is committed to protecting consumers from the dangers of unapproved product